What legal and safety considerations apply when prescribing compounded medications for veterinary patients?

Question

Accepted Answer

Compounded veterinary medications carry distinct legal obligations and safety risks that differ meaningfully from FDA-approved products. Legal use requires a valid veterinarian-client-patient relationship as a baseline condition. Compounding is permitted only when a veterinarian concludes that a compounded drug — rather than a preexisting approved product — is necessary for an animal with a diagnosed medical condition.3 The Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) governs this framework, and compounding from bulk drug substances is explicitly prohibited under AMDUCA.6 The FDA defines compounding as any manipulation of a drug beyond what is included on the FDA-approved label, including mixing two or more approved drugs into a single dosing form, altering physical form (e.g., crushing tablets), adding flavoring, or creating formulations from bulk chemical ingredients.6 Compounding from bulk active pharmaceutical ingredients is illegal but subject to enforcement discretion under specific conditions. The FDA may waive enforcement when the drug is intended for a specific nonfood animal, is distinguishable from any comparable FDA-approved drug in ways that produce a clinical difference, is produced in the absence of an FDA-approved alternative, is compounded in accordance with U.S. Pharmacopeial Convention standards, is made from bulk ingredients produced in registered establishments accompanied by a certificate of analysis, and is labeled with the species, patient name, and owner name — with serious adverse events reported to the FDA within 15 days.8 Gabapentin, for example, is not listed as an accepted bulk chemical ingredient in FDA draft guidance GFI 256, meaning compounding it from bulk substances falls outside this framework even when USP chapter 795 standards are otherwise followed.5 Potency variability is a documented and clinically significant safety risk. Compounded chlorambucil potency ranged from 71–104% of labeled strength, and compounded